Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Buti

Showing results (691-700 of 1,095) with videos related to

Pageof 110
Sort By:
Immunotherapy|August 6, 2024
Differential impact of lipid profile according to neutrophil-to-lymphocyte ratio status in patients with advanced cancer treated with immunotherapyFabiana Perrone, Federica Pecci, Michele Maffezzoli, et al.
Nutrients|March 10, 2022
Weak Association between Skin Autofluorescence Levels and Prediabetes with an ILERVAS Cross-Sectional StudyEnric Sánchez, Mohsen Kerkeni, Marta Hernández, et al.
Epilepsia|June 15, 2007
Idiopathic epilepsies with seizures precipitated by fever and SCN1A abnormalitiesCarla Marini, Davide Mei, Teresa Temudo, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 25, 2025
Unveiling street art: A multimodal and multitechnique approach for analyzing and mapping painting materials on large muralsFrancesca Sabatini, Fauzia Albertin, Brenda Doherty, et al.
Lung Cancer (Amsterdam, Netherlands)|August 10, 2020
Soluble PD-L1 and Circulating CD8+PD-1+ and NK Cells Enclose a Prognostic and Predictive Immune Effector Score in Immunotherapy Treated NSCLC patientsG Mazzaschi, R Minari, A Zecca, et al.
Alimentary Pharmacology & Therapeutics|October 13, 2017
HBeAg levels at week 24 predict response to 8 years of tenofovir in HBeAg-positive chronic hepatitis B patientsD Wong, M Littlejohn, L Yuen, et al.
Gut|April 12, 2012
Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosisRoeland Zoutendijk, Jurrien G P Reijnders, Fabien Zoulim, et al.
Diagnostics (Basel, Switzerland)|December 24, 2021
Assessing Liver Fibrosis Using the FIB4 Index in the Community SettingAlbert Blanco-Grau, Pablo Gabriel-Medina, Francisco Rodriguez-Algarra, et al.
JHEP Reports : Innovation in Hepatology|September 23, 2024
Implementing a new HCV model of care for people who use drugsAndrea Herranz Mochales, Camila A Picchio, Aina Nicolàs, et al.
Therapeutic Advances in Gastroenterology|September 2, 2021
Barriers to linkage to care in hepatitis C patients with substance use disorders and dual diagnoses, despite centralized managementLara Grau-López, Cristina Marcos-Fosch, Constanza Daigre, et al.
Pageof 110

Showing results (691-700 of 1,095) with videos related to

Sort By:
Pageof 110
Immunotherapy|August 6, 2024
Differential impact of lipid profile according to neutrophil-to-lymphocyte ratio status in patients with advanced cancer treated with immunotherapyFabiana Perrone, Federica Pecci, Michele Maffezzoli, et al.
Nutrients|March 10, 2022
Weak Association between Skin Autofluorescence Levels and Prediabetes with an ILERVAS Cross-Sectional StudyEnric Sánchez, Mohsen Kerkeni, Marta Hernández, et al.
Epilepsia|June 15, 2007
Idiopathic epilepsies with seizures precipitated by fever and SCN1A abnormalitiesCarla Marini, Davide Mei, Teresa Temudo, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 25, 2025
Unveiling street art: A multimodal and multitechnique approach for analyzing and mapping painting materials on large muralsFrancesca Sabatini, Fauzia Albertin, Brenda Doherty, et al.
Lung Cancer (Amsterdam, Netherlands)|August 10, 2020
Soluble PD-L1 and Circulating CD8+PD-1+ and NK Cells Enclose a Prognostic and Predictive Immune Effector Score in Immunotherapy Treated NSCLC patientsG Mazzaschi, R Minari, A Zecca, et al.
Alimentary Pharmacology & Therapeutics|October 13, 2017
HBeAg levels at week 24 predict response to 8 years of tenofovir in HBeAg-positive chronic hepatitis B patientsD Wong, M Littlejohn, L Yuen, et al.
Gut|April 12, 2012
Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosisRoeland Zoutendijk, Jurrien G P Reijnders, Fabien Zoulim, et al.
Diagnostics (Basel, Switzerland)|December 24, 2021
Assessing Liver Fibrosis Using the FIB4 Index in the Community SettingAlbert Blanco-Grau, Pablo Gabriel-Medina, Francisco Rodriguez-Algarra, et al.
JHEP Reports : Innovation in Hepatology|September 23, 2024
Implementing a new HCV model of care for people who use drugsAndrea Herranz Mochales, Camila A Picchio, Aina Nicolàs, et al.
Therapeutic Advances in Gastroenterology|September 2, 2021
Barriers to linkage to care in hepatitis C patients with substance use disorders and dual diagnoses, despite centralized managementLara Grau-López, Cristina Marcos-Fosch, Constanza Daigre, et al.
Pageof 110